Thanks to the Supreme Court, it may soon become slightly easier to get the  cheaper generic version of some medications.  In the case of FTC v. Actavis, Inc. the Court decided 5-3 that the FTC has the power to try to stop “pay for delay” on anti-trust grounds.  This is a practice in which drug [...]

Over the passed few years, the price of common brand name prescription drugs have experienced an incredible level of inflation significantly higher than both regular inflation and even medical inflation, according to the Government Accountability Office. Yet, at the same time, the cost of common generic drugs has fallen. Here we have another great reminder [...]

Anna Eshoo (D-PhRMA) may be the author of the language granting drug companies endless monopolies on biologic drugs, but she couldn’t have done it without the help of her good friend Jane Harman.  A new letter from the Winograd campaign says: The latest health insurance reform bill includes an amendment, supported by Jane Harman, member [...]